// App-Quantinova.ai

15960 2014 AHA : Activation of TRAF2-NF-?B Signaling suppresses Mitochondrial Perturbations in Doxorubicin Cardiotoxicity

Researchers

Presenter

  • Lorrie A Kirshenbaum

Principal Investigators

  • N/A

Medical Centers

  • St. Boniface Res Ctr, Winnipeg, MB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Cardiotoxicity

  • Congestive heart failure

Biomarkers

  • B-cell lymphoma 2

  • Nucleoside diphosphate kinase A

  • Proto-oncogene tyrosine-protein kinase ROS

  • RalA Binding Protein 1

Drug/Treatment

  • Doxorubicin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved